What we found on the web about JANUVIA
Sitagliptin (INN; previously identified as MK-0431, trade name Januvia) is an oral antihyperglycemic (anti-diabetic drug) of the dipeptidyl peptidase-4 (DPP-4) inhibitor class ...
The first agent of the class - sitagliptin (marketed by Merck_&_Co. under the trade name Januvia) - was approved by the FDA in 2006. [1] Sitagliptin entered the Australian drug market in ...
Enrollment. CRIXIVAN ® (indinavir sulfate) ISENTRESS ® (raltegravir) GARDASIL ® [Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recombinant Vaccine]
Januvia is a new FDA approved oral diabetes medicine that helps control blood sugar levels people with type 2 diabetes, along with diet and exercise. It works by regulating the ...
A new oral medication called Januvia (sitagliptin phosphate) has been approved by the FDA for management of Type 2 diabetes. It's the first in a new class of drugs called DPP-4 ...
Find patient medical information for Januvia Oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings
Januvia WisdomCard ™ Our Guides and Physician Review team have organized the Top 10 Health Resources on Januvia and compiled helpful research notes below.
WORLD DIABETES DAY COMING SOON: NOV. 14, 2009 Get ready for the Big Blue Test! NOVO NORDISK WINS DESIGN AWARD FOR NEW NEEDLE New NovoTwist for use with the FlexPen features super ...
Some of the most common side effects of Januvia include nausea, abdominal pain, and diarrhea. This eMedTV segment describes Januvia side effects, including some that may be serious ...
It's possible that Januvia and Galvus, although from the same class, really do work differently, and that the problems identified with Galvus are unique.
Januvia is a prescription medicine that can help control blood sugar in people with type 2 diabetes. This eMedTV article explains how Januvia works, identifies some potential side ...
9762707 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use JANUVIA safely and effectively. See full prescribing information for ...
Here is what users have to say about JANUVIA

Sitagliptin (INN; previously identified as MK-0431, trade name Januvia) is an oral antihyperglycemic (anti-diabetic drug) of the dipeptidyl peptidase-4 (DPP-4) inhibitor class, Sitagliptin being the only second generation DPP-4 inhibitor currently available in the USA. This enzyme-inhibiting drug is used either alone or in combination with other oral antihyperglycemic agents (such as metformin or a thiazolidinedione) for treatment of diabetes mellitus type 2. The benefit of this medicine is its lower side-effects (e.g., less hypoglycemia, less weight gain) in the control of blood glucose values. Exenatide (Byetta) also works by its effect on the incretin system.

Welcome to CWAnswers

CWAnswers is your guide to the sprawling world wide web. The directory aims to provide a useful guide made by users. You can share your knowledge as well - simply register and edit your first entry. For questions just contact the team at support - at - cwanswers.com.

Weblinks

Top 10

Things you find nowhere else.

Comments

You must be logged in to post a comment.

No comments yet on this topic. Be the first one!